Favalli C - Search Results

1

Tazarotene as alternative topical treatment for onychomycosis.

Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S, Bianchi L, Orlandi A. Campione E, et al. Among authors: favalli c. Drug Des Devel Ther. 2015 Feb 16;9:879-86. doi: 10.2147/DDDT.S69946. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25733808 Free PMC article. Clinical Trial.

2

Simple enzymatic method for rapid identification of a Staphylococcus aureus subspecies aureus biovar.

Fontana C, Laratta E, Marino D, Pistoia ES, Favalli C. Fontana C, et al. Among authors: favalli c. Eur J Clin Microbiol Infect Dis. 1997 Sep;16(9):689-92. doi: 10.1007/BF01708562. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9352265

3

Comparison of an enzyme immunoassay versus a rapid latex test for serodiagnosis of Helicobacter pylori infection.

Fontana C, Pietroiusti A, Mastino A, Pistoia ES, Marino D, Magrini A, Galante A, Favalli C. Fontana C, et al. Among authors: favalli c. Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):239-40. doi: 10.1007/s100960050469. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10795603 No abstract available.

4

A multi-target real-time PCR assay for rapid identification of meningitis-associated microorganisms.

Favaro M, Savini V, Favalli C, Fontana C. Favaro M, et al. Among authors: favalli c. Mol Biotechnol. 2013 Jan;53(1):74-9. doi: 10.1007/s12033-012-9534-7. Mol Biotechnol. 2013. PMID: 22450734

5

Historical review on thymosin α1 in oncology: preclinical and clinical experiences.

Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, Camerini R, Palamara AT, Favalli C, Mastino A, Serafino A, Sinibaldi Vallebona P. Garaci E, et al. Among authors: favalli c. Expert Opin Biol Ther. 2015;15 Suppl 1:S31-9. doi: 10.1517/14712598.2015.1017466. Epub 2015 Jun 22. Expert Opin Biol Ther. 2015. PMID: 26096345 Review.

6

In vivo cocaine administration influences lymphokine production and humoral immune response.

Di Francesco P, Marini S, Pica F, Favalli C, Tubaro E, Garaci E. Di Francesco P, et al. Among authors: favalli c. Immunol Res. 1992;11(1):74-9. doi: 10.1007/BF02918610. Immunol Res. 1992. PMID: 1602184

7

Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.

Mastino A, Favalli C, Grelli S, Rasi G, Pica F, Goldstein AL, Garaci E. Mastino A, et al. Among authors: favalli c. Int J Cancer. 1992 Feb 1;50(3):493-9. doi: 10.1002/ijc.2910500327. Int J Cancer. 1992. PMID: 1735618

8

Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection.

Garaci E, Rocchi G, Perroni L, D'Agostini C, Soscia F, Grelli S, Mastino A, Favalli C. Garaci E, et al. Among authors: favalli c. Int J Clin Lab Res. 1994;24(1):23-8. doi: 10.1007/BF02592405. Int J Clin Lab Res. 1994. PMID: 7910053 Clinical Trial.

9

Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a.

Garaci E, Lopez M, Bonsignore G, Della Giulia M, D'Aprile M, Favalli C, Rasi G, Santini S, Capomolla E, Vici P, et al. Garaci E, et al. Among authors: favalli c. Eur J Cancer. 1995 Dec;31A(13-14):2403-5. doi: 10.1016/0959-8049(95)00477-7. Eur J Cancer. 1995. PMID: 8652276 Clinical Trial.

10

Combination therapy with BRMs in cancer and infectious diseases.

Garaci E, Pica F, Rasi G, Palamara AT, Favalli C. Garaci E, et al. Among authors: favalli c. Mech Ageing Dev. 1997 Jun;96(1-3):103-16. doi: 10.1016/s0047-6374(97)01895-2. Mech Ageing Dev. 1997. PMID: 9223114 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page